ONWARD Medical announces first implant in ARC-IM clinical feasibility study
ONWARD Medical N.V. said it has announced the first implant in the EIGER clinical feasibility study evaluating its ARC-IM system to restore mobility after spinal cord injury.
EINDHOVEN, the Netherlands, Sept.
03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the first implant in the EIGER clinical…